Acute renal failure

New England Journal of Medicine

Volumn 334, Issue 22, 1996, Pages 1448-1460

  Thadhani, Ravi ^a   Pascual, Manuel ^a   Bonventre, Joseph V ^a,b,c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE KIDNEY FAILURE; HUMAN; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; ANIMAL MODEL; CLINICAL TRIAL; DIALYSIS; DRUG INDUCED DISEASE; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY BIOPSY; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; TREATMENT INDICATION; URINALYSIS;

HUMANS; KIDNEY FAILURE, ACUTE; RISK FACTORS;

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTINEOPLASTIC AGENT; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CEPHALOSPORIN DERIVATIVE; CISPLATIN; CONTRAST MEDIUM; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FOSCARNET; FUROSEMIDE; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; INTEGRIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; MANNITOL; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PENTAMIDINE; SOMATOMEDIN C; TACROLIMUS; UNINDEXED DRUG; VASODILATOR AGENT;

EID: 0030606570     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605303342207     Document Type: Review

References (153)

1. Novis BK, Roizen MF, Aronson S, Thisted RA. Association of preoperative risk factors with postoperative acute renal failure. Anesth Analg 1994; 78:143-9.
2. Moore RD, Smith CR, Lipsky JJ, Mellits ED, Lietman PS. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984;100:352-7.
3. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
4. Zanardo G, Michielon P, Paccagnella A, et al. Acute renal failure in the patient undergoing cardiac operation: prevalence, mortality rate, and main risk factors. J Thorac Cardiovasc Surg 1994;107:1489-95.
5. Turney JH, Marshall DH, Brownjohn AM, Ellis CM, Parsons FM. The evolution of acute renal failure, 1956-1988. Q J Med 1990;74:83-104.
6. Hou SH, Bushinsky DA, Wish JB, Cohen JJ, Harrington JT. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8.
7. Kaufman J, Dhakal M, Patel B, Hamburger R. Community-acquired acute renal failure. Am J Kidney Dis 1991;17:191-8.
8. Shusterman N, Strom BL, Murray TG, Morrison G, West SL, Maislin G. Risk factors and outcome of hospital-acquired acute renal failure: clinical epidemiologic study. Am J Med 1987;83:65-71.
9. Myers BD, Moran SM. Hemodynamically mediated acute renal failure. N Engl J Med 1986;314:97-105.
10. Corwin HL, Teplick RS, Schreiber MJ, Fang LS, Bonventre JV, Coggins CH. Prediction of outcome in acute renal failure. Am J Nephrol 1987;7:8-12.
11. Cameron JS. Acute renal failure -the continuing challenge. Q J Med 1986;59:337-43.
12. Davidman M, Olson P, Kohen J, Leither T, Kjellstrand C. Iatrogenic renal disease. Arch Intern Med 1991;151:1809-12.
13. Shankel SW, Johnson DC, Clark PS, Shankel TL, O'Neil WM Jr. Acute renal failure and glomerulopathy caused by nonsteroidal anti-inflammatory drugs. Arch Intern Med 1992;152:986-90.
14. Pascual J, Liano F, Ortuno J. The elderly patient with acute renal failure. J Am Soc Nephrol 1995;6:144-53.
15. Hricik DE, Browning PJ, Kopelman R, Goorno WE, Madias NE, Dzau VJ. Captopril-induced functional renal insufficiency in patients with bilateral renal-artery stenoses or renal-artery stenosis in a solitary kidney. N Engl J Med 1983;308:373-6.
16. Bridoux F, Hazzan M, Pallot JL, et al. Acute renal failure after the use of angiotensin-converting-enzyme inhibitors in patients without renal artery stenosis. Nephrol Dial Transplant 1992;7:100-4.
17. Abuelo JG. Diagnosing vascular causes of renal failure. Ann Intern Med 1995;123:601-14.
18. Kahan BD. Cyclosporine. N Engl J Med 1989;321:1725-38.
19. Textor SC, Wiesner R, Wilson DJ, et al. Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients. Transplantation 1993;55:1332-9.
20. Norman RW, Mack FG, Awad SA, Belitsky P, Schwartz RD, Lannon SG. Acute renal failure secondary to bilateral ureteric obstruction: review of 50 cases. Can Med Assoc J 1982;127:601-4.
21. Feest TG, Round A, Hamad S. Incidence of severe acute renal failure in adults: results of a community based study. BMJ 1993;306:481-3.
22. Richet G, Mignon F, Morel-Maroger L, et al. Rôle de l'obstruction uratique massive des lumières tubulaires survenue au cours du traitement d'une hemopathie maligne lors d'une insuffisance rénale aiguë. Ann Med Interne 1969;120:657-60.
23. Esnault V, Delcroix C, Dubigeon P, Guenel J. Insuffisa̧nce rénale aiguë réversible avec oxalose tabulaire: rôle possible de facteurs nutritionnels. Nephrologie 1988;9:277-80.
24. Sawyer MH, Webb DE, Balow JE, Straus SE. Acyclovir-induced renal failure: clinical course and histology. Am J Med 1988;84:1067-71.
25. Carbone LG, Bendixen B, Appel GB. Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome. Am J Kidney Dis 1988;12:72-5.
26. Pitman SW, Frei E III. Weekly methotrexate-calcium leucovorin rescue: effect of alkalinization on nephrotoxicity; pharmacokinetics in the CNS; and use in CNS non-Hodgkin's lymphoma. Cancer Treat Rep 1977;61: 695-701.
27. Shapiro SR, Bennett AH. Recovery of renal function after prolonged unilateral ureteral obstruction. J Urol 1976;115:136-40.
28. Paul AB, Love C, Chisholm GD. The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer. Br J Urol 1994;74: 642-5.
29. Chugh KS, Jha V, Sakhuja V, Joshi K. Acute renal cortical necrosis - a study of 113 patients. Ren Fail 1994;16:37-47.
30. Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 1990;322:825-9.
31. Meyer KB, Madias NE. Cisplatin nephroloxicity. Miner Electrolyte Metab 1994;20:201-13.
32. Kyle RA. Monoclonal proteins and renal disease. Annu Rev Med 1994;45: 71-7.
33. Harris KP, Hattersley JM, Feehally J, Walls J. Acute renal failure associated with haematological malignancies: a review of 10 years experience. Eur J Haematol 1991:47:119-22.
34. Rao TK, Friedman EA. Outcome of severe acute renal failure in patients with acquired immunodeficiency syndrome. Am J Kidney Dis 1995;25: 390-8.
35. Cooper K, Bennett WM. Nephrotoxicity of common drugs used in clinical practice. Arch Intern Med 1987;147:1213-8.
36. Cameron JS. Allergic interstitial nephritis: clinical features and pathogenesis. Q J Med 1988;66:97-115.
37. Galpin JE, Shinaberger JH, Stanley TM, et al. Acute interstitial nephritis due to methicillin. Am J Med 1978;65:756-65.
38. Jennette JC, Falk RJ. The diagnosis and management of glomerulonephritis and vasculitis presenting as acute renal failure. Med Clin North Am 1990;74:893-908.
39. Mason PD, Pusey CD. Glomerulonephritis: diagnosis and treatment. BMJ 1994;309:1557-63. [Erratum, BMJ 1995;310:116]
40. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and non-ionic contrast media in 1196 patients: a randomized trial: the Iohexol Cooperative Study. Kidney Int 1995;47:254-61.
41. Thadhani RI, Camargo CA Jr, Xavier RJ, Fang LS, Bazari H. Atheroembolic renal failure after invasive procedures: natural history based on 52 histologically proven cases. Medicine (Baltimore) 1995;74:350-8.
42. Schepens MA, Defauw JJ, Hamerlijnck RP, De Geest R, Vermeulen FE. Surgical treatment of thoracoabdominal aortic aneurysms by simple cross-clamping: risk factors and late results. J Thorac Cardiovasc Surg 1994; 107:134-42.
43. Liano F, Garcia-Martin F, Gallego A, et al. Easy and early prognosis in acute tubular necrosis: a forward analysis of 228 cases. Nephron 1989;51: 307-13.
44. Pascual J, Orofino L, Liano F, et al. Incidence and prognosis of acute renal failure in older patients. J Am Geriatr Soc 1990;38:25-30.
45. Dixon BS, Anderson RJ. Nonoliguric acute renal failure. Am J Kidney Dis 1985;6:71-80.
46. Spurney RF, Fulkerson WJ, Schwab SJ. Acute renal failure in critically ill patients: prognosis for recovery of kidney function after prolonged dialysis support. Crit Care Med 1991;19:8-11.
47. Turney JH. Why is mortality persistently high in acute renal failure? Lancet 1990;335:971.
48. Woodrow G, Turney JH. Cause of death in acute renal failure. Nephrol Dial Transplant 1992;7:230-4.
49. Chertow GM, Christiansen CL, Cleary PD, Munro C, Lazarus JM. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995;155:1505-11.
50. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994;331: 1338-42.
51. Maher ER, Robinson KN, Scoble JE, et al. Prognosis of critically-ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 1989;72:857-66.
52. Schiffl H, Lang SM, Konig A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994;344:570-2.
53. Ruffing KA, Hoppes P, Blend D, Cugino A, Jarjoura D, Whittier FC. Eosinophils in urine revisited. Clin Nephrol 1994;41:163-6.
54. Miller TR, Anderson RJ, Linas SL, et al. Urinary diagnostic indices in acute renal failure: a prospective study. Ann Intern Med 1978;89:47-50.
55. Finn WF. Diagnosis and management of acute tubular necrosis. Med Clin North Am 1990;74:873-91.
56. Maillet PJ, Pelle-Francoz D, Laville M, Gay F, Pinet A. Nondilated obstructive acute renal failure: diagnostic procedures and therapeutic management. Radiology 1986;160:659-62.
57. Solez K, Morel-Maroger L, Sraer JD. The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 1979;58:362-76.
58. Wilson DM, Turner DR, Cameron JS, Ogg CS, Brown CB, Chantler C. Value of renal biopsy in acute intrinsic renal failure. BMJ 1976;2:459-61.
59. Richards NT, Darby S, Howie AJ, Adu D, Michael J. Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant 1994;9:1255-9.
60. Schena FP, Gesualdo L. Renal biopsy - beyond histology and immunofluorescence. Nephrol Dial Transplant 1994;9:1541-4.
61. Parrish AE. Complications of percutaneous renal biopsy: a review of 37 years' experience. Clin Nephrol 1992;38:135-41.
62. Brezis M, Rosen S. Hypoxia of the renal medulla - its implications for disease. N Engl J Med 1995;332:647-55.
63. Bonventre JV. Mechanisms of ischemic acute renal failure. Kidney Int 1993;43:1160-78.
64. Malis CD, Leaf A, Varadarajan GS, et al. Effects of dietary ω3 fatty acids on vascular contractility in preanoxic and postanoxic aortic rings. Circulation 1991;84:1393-401.
65. Conger JD, Robinette JB, Hammond WS. Differences in vascular reactivity in models of ischemic acute renal failure. Kidney Int 1991;39:1087-97.
66. Lindner A, Cutler RE, Goodman G. Synergism of dopamine plus furosemide in preventing acute renal failure in the dog. Kidney Int 1979;16: 158-66.
67. McDonald RH, Goldberg LI, McNay JL, Tuttle EP Jr. Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J Clin Invest 1964;43:1116-24.
68. Flancbaum L, Choban PS, Dasta JF. Quantitative effects of low-dose dopamine on urine output in oliguric surgical intensive care unit patients. Crit Care Med 1994;22:61-8.
69. Szerlip HM. Renal-dose dopamine: fact and fiction. Ann Intern Med 1991; 115:153-4.
70. Baldwin L, Henderson A, Hickman P. Effect of postoperative low-dose dopamine on renal function after elective major vascular surgery. Ann Intern Med 1994;120:744-7.
71. Conger JD. Interventions in clinical acute renal failure: what are the data? Am J Kidney Dis 1995;26:565-76.
72. Thompson BT, Cockrill BA. Renal-dose dopamine: a siren sorg? Lancet 1994;344:7-8.
73. Neumayer HH, Kunzendorf U Schreiber M. Protective effects of calcium antagonists in human renal transplantation. Kidney Int Suppl 1992;36:S87-S93.
74. Ruggenenti P, Perico N, Mosconi L, et al. Calcium channel blockers protect transplant patients from cyclosporine-induced daily renal hypoperfusion. Kidney Int 1993;43:706-11.
75. Neumayer HH, Junge W, Kufner A, Wenning A. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant 1989;4:1030-6.
76. Shaw SG, Weidmann P, Hodler J, Zimmermann A, Paternostro A. Atrial natriuretic factor peptide protects against acute ischemic renal failure in the rat. J Clin Invest 1987;80:1232-7.
77. Rahman SN, Kim GE, Mathew AS, et al. Effects of atrial natriuretic peptide in clinical acute renal failure. Kidney Int 1994;45:1731-8.
78. Sands JM, Neylan JF, Olson RA, O'Brien DP, Whelchel JD, Milch WE. Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol 1991;1:1081-6.
79. Shilliday I, Allison ME. Diuretics in acute renal failure. Ren Fail 1994;16: 3-17.
80. Weisberg LS, Kurnik PB, Kurnik BRC. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. Kidney Int 1994;45:259-65.
81. Rahman SN, Butt AR, DuBose TD, et al. Differential clinical effects of anaritide atrial natriuretic peptide (ANP) in oliguric and non-oliguric ATN. J Am Soc Nephrol 1995;6:474. abstract.
82. Badr KF. Novel mediators of sepsis-associated renal failure. Semin Nephrol 1994;14:3-7.
83. Kon V, Yoshioka T, Fogo A, Ichikawa I. Glomerular actions of endothelin in vivo. J Clin Invest 1989;83:1762-7.
84. Chan L, Chittinandana A, Shapiro JI, Shanley PF, Schrier RW. Effect of an endothelin-receptor antagonist on ischemic acute renal failure. Am J Physiol 1994;266:F135-F138.
85. Morrissey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994;45:998-1005.
86. Brezis M, Heyman SN, Dinour D, Epstein FH, Rosen S. Role of nitric oxide in renal medullary oxygenation: studies in isolated and intact rat kidneys. J Clin Invest 1991;88:390-5.
87. Mason JC, Joeris B, Welsch J, Kriz W. Vascular congestion in ischemic renal failure: the role of cell swelling. Miner Electrolyte Metab 1989;15:114-24.
88. Vetterlein F, Pethö A, Schmidt G. Distribution of capillary blood flow in rat kidney during postischemic renal failure. Am J Physiol 1986;251: H510-H519.
89. Schmid-Schonbein GW. Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed Proc 1987;46:2397-401.
90. Spencer AJ, LeFurgey A, Ingram P, Mandel LJ. Elemental microanalysis of organelles in proximal tubules. II. Effects of oxygen deprivation. J Am Soc Nephrol 1991;1:1321-33.
91. Molitoris BA. Ischemia-induced loss of epithelial polarity: potential role of the actin cytoskeleton. Am J Physiol 1991;260:F769-F778.
92. Kellerman PS, Clark RA, Hoilien CA, Linas SL, Molitoris BA. Role of microfilaments in maintenance of proximal tubule structural and functional integrity. Am J Physiol 1990;259:F279-F285.
93. Abbate M, Bonventre JV, Brown D The microtubule network of renal epithelial cells is disrupted by ischemia and reperfusion. Am J Physiol 1994; 267:F971-F978.
94. Fish EM, Molitoris BA. Alterations in epithelial polarity and the pathogenesis of disease states. N Engl J Med 1994;330:1580-8.
95. +-ATPaSe during ischemia. Am J Physiol 1992;263:F488-F495.
96. Goligorsky MS, DiBona GF. Pathogenetic role of Arg-Gly-Asp-recognizing integrins in acute renal failure. Proc Natl Acad Sci U S A 1993;90: 5700-4.
97. Racusen LC, Fivush BA, Li Y-L, Slatnick I, Solez K. Dissociation of tubular cell detachment and tubular cell death in clinical and experimental "acute tubular necrosis." Lab Invest 1991;64:546-56.
98. Noiri E, Gailit J, Sheth D, et al. Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int 1994;46:1050-8.
99. Bonventre JV, Weinberg JM. Kidney preservation ex vivo for transplantation. Annu Rev Med 1992;43:523-53.
100. Malis CD, Cheung JY, Leaf A, Bonventre JV. Effects of verapamil in models of ischemic acute renal failure in the rat. Am J Physiol 1983;245:F735-F742.
101. Mohaupt M, Kramer HJ. Acute ischemic renal failure, review of experimental studies on pathophysiology and potential protective interventions. Ren Fail 1989-90;11:177-85.
102. Lieberthal W, Levinsky NG. Treatment of acute tubular necrosis. Semin Nephrol 1990;10:571-83.
103. Corwin HL, Bonventre JV. Factors influencing survival in acute renal failure. Semin Dial 1989;2:220-5.
104. Weinstein JM, Heyman S, Brezis M. Potential deleterious effect of furosemide in radiocontrast nephropathy. Nephron 1992;62:413-5.
105. 2+ exchange as a major calcium influx pathway in kidney cells. J Biol Chem 1985;260:14998-5007.
106. Kribben A, Wieder ED, Wetzels JFM, et al. Evidence for role of cytosolic free calcium in hypoxia-induced proximal tubule injury. J Clin Invest 1994; 93:1922-9.
107. Johnson KJ, Weinberg JM. Postischemic renal injury due to oxygen radicals. Curr Opin Nephrol Hypertens 1993;2:625-35.
108. Siegel NJ, Glazier WB, Chaudry IH, et al. Enhanced recovery from acute renal failure by the postischemic infusion of adenine nucleotides and magnesium chloride in rats. Kidney Int 1980;17:338-49.
109. Rosen S, Spokes K, Brezis M, Silva P, Epstein FH. Toxicity of adenine nucleotides in the isolated perfused kidney: selective destruction of the S2 segment of the proximal tubule. Virchows Arch B Cell Pathol Incl Mol Pathol 1991;61:169-77.
110. Inscho EW, Ohishi K, Cook AK, Belott TP, Navar LG. Calcium activation mechanisms in the renal microvascular response to extracellular ATP. Am J Physiol 1995;268:F876-F884.
111. Sevanian A, Kim E. Phospholipase A2 dependent release of fatty acids from peroxidized membranes. J Free Radicals Biol Med 1985;1:263-71.
112. Klausner JM, Paterson IS, Goldman G, et al. Postischemic renal injury is mediated by neutrophils and leukotrienes. Am J Physiol 1989;256:F794-F802.
113. Schumer M, Colombel MC, Sawczuk IS, et al. Morphologic, biochemical, and molecular evidence of apoptosis during the reperfusion phase after brief periods of renal ischemia. Am J Pathol 1992;140:831-8.
114. Beeri R, Symon Z, Brezis M, et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 1995;47: 1806-10.
115. Olsen S, Burdick JF, Keown PA, Wallace AC, Racusen LC, Solez K. Primary acute renal failure ('acute tubular necrosis') in the transplanted kidney: morphology and pathogenesis. Medicine (Baltimore) 1989;68:173-87.
116. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 1994;76:301-14.
117. Marks RM, Todd RF III, Ward PA. Rapid induction of neutrophil-endothelial adhesion by endothelial complement fixation. Nature 1989;339:314-7.
118. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990;249:146-51.
119. Grino JM. BN52021: a platelet activating factor antagonist for preventing post-transplant renal failure: a double-blind, randomized study. Ann Intern Med 1994;121:345-7.
120. Kelly KJ, Williams WW, Colvin RB, et al. Intercellular adhesion molecule-1 deficient mice are protected against ischemic renal injury. J Clin Invest 1996;97:1056-63.
121. Granger DN, Korthuis RJ. Physiologic mechanisms of postischemic tissue injury. Annu Rev Physiol 1995;57:311-32.
122. Albelda SM, Smith CW, Ward PA, Adhesion molecules and inflammatory injury. FASEB J 1994;8:504-12.
123. Kelly KJ, Williams WW Jr, Colvin RB, Bonventre JV. Antibody to intercellular adhesion molecule 1 protects the kidney against ischemic injury. Proc Natl Acad Sci U S A 1994;91:812-6.
124. Haug CE, Colvin RB, Delmonico FL, et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993;55:766-72.
125. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995;59:962-8.
126. Halloran PF, Aprile MA, Farewell V, et al. Early function as the principal correlate of graft survival: a multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988;46:223-8.
127. Goes N, Urmson J, Ramassar V, Halloran PF. Ischemic acute tubular necrosis induces an extensive local cytokine response: evidence for induction of interferon-gamma, transforming growth factor-beta 1, granulocyte-macrophage colony-stimulating factor, interleukin-2, and interleukin-10. Transplantation 1995;59:565-72.
128. Vakeva A, Meri S, Lehto T, Laurila P. Activation of the terminal complement cascade in renal infarction. Kidney Int 1995;47:918-26.
129. Kilgore KS, Shen JP, Miller BF, Ward PA, Warren JS. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. J Immunol 1995;155:1434-41.
130. Herskowitz A, Choi S, Ansari AA, Wesselingh S. Cytokine mRNA expression in postischemic/reperfused myocardium. Am J Pathol 1995;146:419-28.
131. Baldwin W III, Pruitt SK, Brauer RB, Daha MR, Sanfilippo F. Complement in organ transplantation: contributions to inflammation, injury, and rejection. Transplantation 1995;59:797-808.
132. Eason JD, Pascual M, Wee S, et al. Evaluation of recombinant human soluble dimeric tumor necrosis factor receptor for prevention of OKT3-associated acute clinical syndrome. Transplantation 1996;61:224-8.
133. Levin ER. Endothelins N Engl J Med 1995;333:356-63.
134. Witzgall R, Brown D, Schwarz C, Bonventre JV. Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney: evidence for a heterogeneous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 1994;93:2175-88.
135. Hammerman MR, Miller SB. Therapeutic use of growth factors in renal failure. J Am Soc Nephrol 1994;5:1-11.
136. Safirstein RL, Bonventre JV. Molecular response to ischemic and nephrotoxic acute renal failure. In: SchlöndorfT D, Bonventre JV, eds. Molecular nephrology: kidney function in health and disease. New York: Marcel Dekker, 1995:839-54.
137. Rogers SA, Miller SB, Hammerman MR. Triiodothyronine stimulates renal epidermal growth factor expression in adult ral. Am J Physiol 1995; 268:F128-F134.
138. Franklin S, Moulton M, Hammerman MR, Miller SB. Sustained improvement of renal function and amelioration of symptoms in patients with chronic renal failure treated with insulin-like growth factor-1. J Am Soc Nephrol 1995;6:387. abstract.
139. Bellomo R, Parkin G, Love J, Boyce N. A prospective comparative study of continuous arteriovenous hemodiafiltration and continuous venovenous hemodiafiltration in critically ill patients. Am J Kidney Dis 1993;21:400-4.
140. Mehta RL. Therapeutic alternatives to renal replacement for critically ill patients in acute renal failure. Semin Nephrol 1994;14:64-82.
141. Bellomo R, Tipping P, Boyce N. Continuous veno-venous hemofillration with dialysis removes cytokines from the circulation of septic patients. Crit Care Med 1993;21:522-6.
142. Sponsel H, Conger JD. Is parenteral nutrition therapy of value in acute renal failure patients? Am J Kidney Dis 1995;25:96-102.
143. Howdieshell TR, Blalock WE, Bowen PA, Hawkins ML, Hess C. Management of post-traumatic acute renal failure with peritoneal dialysis. Am Surg 1992;58:378-82.
144. Hakim RM, Breillatt J, Lazarus JM, Port FK. Complement activation and hypersensitivity reactions to dialysis membranes. N Engl J Med 1984;311: 878-82.
145. Arnaout MA, Hakim RM, Todd RF III, Dana N, Colten HR. Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis. N Engl J Med 1985;312:457-62.
146. Combe C, Pourtein M, de Precigout V, et al. Granulocyte activation and adhesion molecules during hemodialysis with cuprophane and a high-flux biocompatible membrane. Am J Kidney Dis 1994;24:437-42.
147. Schulman G, Fogo A, Gung A, Badr K, Hakim RM. Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991;40:1069-74.
148. Cheung AK. Biocompatibility of hemodialysis membranes. J Am Soc Nephrol 1990;1:150-61.
149. Hakim RM. Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 1993;44:484-94.
150. Pascual M, Schifferli JA. Adsorption of complement factor D by polyacrylonitrile dialysis membranes. Kidney Int 1993;43:903-11.
151. Hakim RM, Tolkoff-Rubin N, Himmelfarb J, Wingard RL, Parker RA. A multicenter comparison of bioincompatible and biocompatible membranes in the treatment of acute renal failure. J Am Soc Nephrol 1994;5:394. abstract.
152. Gillum DM, Dixon BS, Yanover MJ, et al. The role of intensive dialysis in acute renal failure. Clin Nephrol 1986;25:249-55.
153. Pascual M, Tolkoff-Rubin N, Schifferli JA. Is adsorption an important characteristic of dialysis membranes? Kidney Int 1996;49:309-13.